Nalaganje...

Small bowel adenocarcinomas—evolving paradigms and therapy options

Small bowel cancers account for 3% of all gastrointestinal malignancies. Small bowel adenocarcinomas represent a third of all small bowel cancers. Rarity of small bowel adenocarcinomas restricts molecular understanding and presents unique diagnostic and therapeutic challenges. Better cross-sectional...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Nat Rev Clin Oncol
Main Authors: Raghav, Kanwal, Overman, Michael J.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6076441/
https://ncbi.nlm.nih.gov/pubmed/23897080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2013.132
Oznake: Označite
Brez oznak, prvi označite!